Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education
Seulji Kim, Seong-Joon Koh
Intest Res. 2022;20(4):389-391.   Published online 2022 Oct 28     DOI: https://doi.org/10.5217/ir.2022.00117
Citations to this article as recorded by Crossref logo
Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting
Luca Degli Esposti, Valentina Perrone, Diego Sangiorgi, Stefania Saragoni, Melania Dovizio, Flavio Caprioli, Fernando Rizzello, Marco Daperno, Alessandro Armuzzi
Digestive and Liver Disease.2024; 56(1): 29.     CrossRef